0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 121-140 of 611 Articles
Editorial |  FREE
Eric D. Peterson, MD, MPH; J. Michael Gaziano, MD; Philip Greenland, MD
JAMA. 2014;311(5):474-476. doi:10.1001/jama.2013.284430.

Editorial |  FREE
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Robert M. Golub, MD
JAMA. 2014;311(5):477-478. doi:10.1001/jama.2013.284432.

Special Communication |  FREE
Paul A. James, MD; Suzanne Oparil, MD; Barry L. Carter, PharmD; et al.
JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427.
Includes: CME, Supplemental Content

Viewpoint | 
Bruce M. Psaty, MD, PhD; Noel S. Weiss, MD, DrPH
JAMA. 2014;311(5):461-462. doi:10.1001/jama.2013.284203.

JAMA Revisited | 
JAMA. 2014;311(4):423. doi:10.1001/jama.2013.279299.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(4):347-348. doi:10.1001/jama.2013.285704.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(4):349. doi:10.1001/jama.2014.61.

Original Investigation |  FREE
Leonard V. Sacks, MBBCh; Hala H. Shamsuddin, MD; Yuliya I. Yasinskaya, MD; et al.
JAMA. 2014;311(4):378-384. doi:10.1001/jama.2013.282542.
Includes: CME, Supplemental Content

Users' Guides to the Medical Literature | 
Xin Sun, PhD; John P. A. Ioannidis, MD, DSc; Thomas Agoritsas, MD; et al.
JAMA. 2014;311(4):405-411. doi:10.1001/jama.2013.285063.
Includes: Supplemental Content

Viewpoint | 
Benjamin Djulbegovic, MD, PhD; Iztok Hozo, PhD; John P. A. Ioannidis, MD, DSc
JAMA. 2014;311(4):355-356. doi:10.1001/jama.2013.283742.

Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;311(3):321. doi:10.1001/jama.2013.283505.
Includes: Supplemental Content

Global Health | 
M. J. Friedrich
JAMA. 2014;311(3):235. doi:10.1001/jama.2013.285742.

Original Investigation |  FREE
Stephen J. Nicholls, MBBS, PhD; John J. P. Kastelein, MD, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2014;311(3):252-262. doi:10.1001/jama.2013.282836.
Includes: Supplemental Content

Editorial | 
Gianna Zuccotti, MD; Edward H. Livingston, MD
JAMA. 2014;311(2):144. doi:10.1001/jama.2013.283819.

Review |  FREE
Susan Z. Yanovski, MD; Jack A. Yanovski, MD, PhD
JAMA. 2014;311(1):74-86. doi:10.1001/jama.2013.281361.
Includes: CME, Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(1):19. doi:10.1001/jama.2013.285449.

Viewpoint | 
Darius N. Lakdawalla, PhD; Anupam B. Jena, MD, PhD; Jason N. Doctor, PhD
JAMA. 2014;311(1):25-26. doi:10.1001/jama.2013.282839.

Viewpoint | 
Leah L. Zullig, PhD, MPH; Eric D. Peterson, MD, MPH; Hayden B. Bosworth, PhD
JAMA. 2013;310(24):2611-2612. doi:10.1001/jama.2013.282818.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Comment & Response  | 
The Popularity of Benzodiazepines, Their Advantages, and Inadequate Pharmacological Alternatives
Vladan Starcevic, MD, PhD, FRANZCP
JAMA Psychiatry
Comment & Response  | 
The Popularity of Benzodiazepines, Their Advantages, and Inadequate Pharmacological Alternatives—Reply
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Internal Medicine
Original Investigation  | 
Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents:  The PARTAGE Study
Athanase Benetos, MD, PhD; Carlos Labat, BSc; Patrick Rossignol, MD, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Abuse-Deterrent Opioid Formulations:  Part of a Public Health Strategy to Reverse the Opioid Epidemic
Hillary V. Kunins, MD, MPH, MS